Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13156ApprovedSmall molecule
Inosine pranobex is a medication used to treat subacute sclerosing panencephalitis. Inosine pranobex (Isoprinosine or Methisoprinol) is a combination of inosine, acetamidobenzoic acid, and dimethylaminoisopropanol used as an antiviral drug.
- Mechanism
- Curator reviewed
Inosine pranobex stimulates cell-mediated immune processes to viral infections.
- Primary indication
- Inosine pranobex is also indicated for mucocutaneous infections due to herpes simplex virus (type 1 and type II) and for treatment of genital warts as adjunctive therapy to podophyllin or carbon dioxide laser.Curator reviewed · 1 structured indication
- Formula / weight
- C52H78N10O17 · 1115.249 g/mol (avg)
- First approval
- Canada, 2012
- Also known as
- Inosine acedobene dimepranol · Inosiplex · Isoprinosine · Methisoprinol
- Code names
- NP-113 · NPT-10381
- Brand names
- Imunovir
Resolves to
Clinical / RWD
Structure
InChIKey
YLDCUKJMEKGGFI-KSIULYHRSA-NSMILESC[C@@H](O)CN(C)C.C[C@@H](O)CN(C)C.C[C@@H](O)CN(C)C.CC(=O)NC1=CC=C(C=C1)C(O)=O.CC(=O)NC1=CC=C(C=C1)C(O)=O.CC(=O)NC1=CC=C(C=C1)C(O)=O.OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CNC2=OWhat you can answer from here — as of July 07, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which other approved drugs treat the same conditions as Inosine pranobex, and which companies have late-stage candidates in those indications?